ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1282

Feasibility and Reliability of the Spondyloarthritis Research Consortium of Canada Sacroiliac Joint Structural Score for Children with Spondyloarthritis

Nancy A. Chauvin1, Walter P. Maksymowych2,3, Robert G. Lambert4, Jacob Jaremko5, David M. Biko1, Timothy G. Brandon6, Joel Paschke3 and Pamela F. Weiss7,8, 1Radiology, Children's Hospital of Philadelphia, Philadelphia, PA, 2Medicine, University of Alberta, Edmonton, AB, Canada, 3CaRE Arthritis, Edmonton, AB, Canada, 4Radiology, University of Alberta, Edmonton, AB, Canada, 5Radiology, Radiology, University of Alberta, Edmonton, AB, Canada, 6Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, 7Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 8Division of Rheumatology, Center for Pediatric Clincial Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Ankylosing spondylitis (AS), Imaging, outcome measures and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Imaging of Rheumatic Diseases - Poster II: XR/CT/PET/MRI

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: There is a critical need for measures to evaluate structural progression in the pediatric sacroiliac joint. We aimed to evaluate the precision and construct validity of the Spondyloarthritis Research Consortium of Canada (SPARCC) sacroiliac joint structural score (SSS) in children with suspected or confirmed juvenile spondyloarthritis.

Methods: The SSS assesses a spectrum of structural lesions of the sacroiliac joint on magnetic resonance imaging (MRI) including fat metaplasia, erosion, backfill, and ankylosis on 5 consecutive slices through the cartilaginous part of the joint. These components are scored 0-20 (backfill and ankylosis) or 0-40 (fat metaplasia, erosion). We developed a pediatric training module that included a detailed description of each SSS component plus sclerosis (0-40), scoring methodology, and numerous examples (Figure). After reviewing the module, 5 readers (1 adult and 3 pediatric radiologists, 1 adult rheumatologist), blinded to clinical details except age, scored 30 studies that included semicoronal T1-weighted sequences. Inter-observer reliability was assessed using intraclass correlation coefficient (ICC). We assessed correlation (construct validity) between the mean SPARCC SSS developers’ scores and disease duration with Spearman correlation. Discrimination was tested by comparing the mean SPARCC SSS developers’ scores between children with and without limited mobility (retained lumbar lordosis, modified Schober <20 cm, or both).

Results: The SSS had face validity and was feasible to score in the 30 pediatric cases with suspected or confirmed spondyloarthritis. 21 (70%) were male and median age was 15.5 years (IQR 12.7-16.8). Median symptom duration was 30 months (IQR 2.3-74.7). The ICCs for the SSS components are shown in the Table. Erosion, backfill, and ankylosis had good reliability (>0.40) while reliability for fat metaplasia and sclerosis were low. 27 (18%), 106 (70%), 44 (29%), 83 (55%), and 13 (9%) of studies had a score>0 for fat metaplasia, erosion, backfill, sclerosis, and ankylosis, respectively. Correlations of symptom duration with each component of the SSS were low (r range -0.13-0.26). SSS components did not discriminate between children with and without limited back mobility.

Conclusion: The SSS was feasible to score and had acceptable reliability for pediatric sacroiliac joint MRI evaluation. Low ICC for fat metaplasia may reflect low frequency of this feature in pediatric SpA or difficulty in assessment since hematopoietic marrow can appear patchy. Low ICC for fat metaplasia and sclerosis highlight the need for additional calibration.

 

 

SSS

Median (IQR),

All readers

All Readers

 

(N=5)

ICC (95% CI)

Pediatric Radiologists (N=3)

ICC (95% CI)

SPARCC developers (N=2)

ICC (95% CI)

Fat metaplasia (0-40)

0 (0-0)

0.37 (0.21-0.56)

0.46 (0.25, 0.67)

0.89 (0.77-0.95)

Erosion (0-40)

4 (0-10)

0.47 (0.29-0.65)

0.39 (0.15, 0.61)

0.72 (0.48-0.86)

Backfill (0-20)

0 (0-1)

0.54 (0.38-0.71)

0.36 (0.14, 0.58)

0.82 (0.56-0.92)

Sclerosis (0-40)

1 (0-5)

0.39 (0.21-0.59)

0.42 (0.17, 0.65)

0.61 (0.08-0.83)

Ankylosis (0-20)

0 (0-0)

0.59 (0.43-0.74)

0.46 (0.24, 0.66)

0.72 (0.49-0.85)

Table. ICC for SSS components. ICC<0.40 is poor, 0.40≤ICC<0.75 is good and ICC≥0.75 is excellent.

 


Disclosure: N. A. Chauvin, None; W. P. Maksymowych, None; R. G. Lambert, None; J. Jaremko, None; D. M. Biko, None; T. G. Brandon, None; J. Paschke, None; P. F. Weiss, None.

To cite this abstract in AMA style:

Chauvin NA, Maksymowych WP, Lambert RG, Jaremko J, Biko DM, Brandon TG, Paschke J, Weiss PF. Feasibility and Reliability of the Spondyloarthritis Research Consortium of Canada Sacroiliac Joint Structural Score for Children with Spondyloarthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/feasibility-and-reliability-of-the-spondyloarthritis-research-consortium-of-canada-sacroiliac-joint-structural-score-for-children-with-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/feasibility-and-reliability-of-the-spondyloarthritis-research-consortium-of-canada-sacroiliac-joint-structural-score-for-children-with-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology